EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Anaerobiosis and Mutations Can Reduce Susceptibility of Pseudomonas aeruginosa to Tobramycin Without Reducing the Cellular Concentration of the Antibiotic

Woravimol Krittaphol iD, Lois W Martin, Greg F Walker iD, Iain L Lamont iD

Pathogens · 2025

DOI: 10.3390/pathogens14020187 ↗

At a glance

Journal article in Pathogens, 2025. Written by Woravimol Krittaphol and 3 co-authors. Institution: School of Pharmacy, University of Otago, Dunedin 9016, New Zealand. Major MEDLINE topics: Pseudomonas aeruginosa, Tobramycin, Anti-Bacterial Agents, Mutation. 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: Otago Medical Research Foundation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Chronic infections of Pseudomonas aeruginosa are commonly treated with tobramycin. During infections, the bacteria can exist under conditions of oxygen deprivation that render them less susceptible to this antibiotic. The aims of this research were to investigate the genetic basis of tobramycin resistance under anaerobic conditions, and to investigate the effects of anaerobiosis and mutations on the cellular concentration of tobramycin. Ten mutants with lowered susceptibility to tobramycin than wild-type bacteria were evolved from a laboratory reference strain under anaerobic conditions. Mutations were identified by genome sequencing. Mutations had arisen most frequently in the fusA1 gene that encodes elongation factor EF-G1A and in genes involved in twitching motility. Cellular concentrations of tobramycin were then measured. Mutations in fusA1 or absence of the MexXY efflux pump that is associated with tobramycin resistance did not alter the cellular tobramycin concentration under either anaerobic or aerobic conditions. Anaerobic growth reduced the cellular concentration of tobramycin, relative to aerobically grown bacteria, in some but not all of five tested P. aeruginosa isolates. Overall, our findings indicate that anaerobiosis and mutations that reduce aminoglycoside effectiveness do not lower the cellular concentration of antibiotic but instead reduce susceptibility through other mechanisms.

Subjects

MeSH terms (MEDLINE)

Pseudomonas aeruginosaTobramycinAnti-Bacterial AgentsMutationDrug Resistance, BacterialAnaerobiosisMicrobial Sensitivity TestsPseudomonas InfectionsHumansBacterial Proteins

Author keywords

MexXYPseudomonas aeruginosaanaerobiosisfusA1resistancetobramycin

Substances

TobramycinAnti-Bacterial AgentsBacterial Proteins

Authors and institutions

  • School of Pharmacy, University of Otago, Dunedin 9016, New Zealand.
  • Department of Biochemistry, University of Otago, Dunedin 9054, New Zealand.

ORCID profiles: Woravimol Krittaphol, Greg F Walker, Iain L Lamont

Funding

  • Otago Medical Research Foundation

Cite

APA

Krittaphol, W., Martin, L. W., Walker, G. F., & Lamont, I. L. (2025). Anaerobiosis and Mutations Can Reduce Susceptibility of Pseudomonas aeruginosa to Tobramycin Without Reducing the Cellular Concentration of the Antibiotic. Pathogens. https://doi.org/10.3390/pathogens14020187

Vancouver

Krittaphol W, Martin LW, Walker GF, Lamont IL. Anaerobiosis and Mutations Can Reduce Susceptibility of Pseudomonas aeruginosa to Tobramycin Without Reducing the Cellular Concentration of the Antibiotic. Pathogens. 2025. doi:10.3390/pathogens14020187

BibTeX
@article{Krittaphol2025,
  author = {Krittaphol, Woravimol and Martin, Lois W and Walker, Greg F and Lamont, Iain L},
  title = {Anaerobiosis and Mutations Can Reduce Susceptibility of Pseudomonas aeruginosa to Tobramycin Without Reducing the Cellular Concentration of the Antibiotic},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14020187}
}
Start for free →